Blood cell labeling with 99mTc: progress and perspectives.

Area of Science:

• Nuclear medicine
• Radiopharmacology
• Hematology

Background:

• Red blood cell labeling with technetium-99m (99mTc) is a mature technology.
• Recent resurgence in interest for labeling leukocytes and platelets with 99mTc.
• Current cell labeling techniques require cell separation and handling before labeling.

Purpose of the Study:

• To summarize and discuss progress in 99mTc blood cell labeling over the last 3.5 years.
• To highlight emerging techniques for reliable and reproducible cell labeling.
• To review recent efforts using monoclonal antibodies for cell labeling.

Main Methods:

• Review of scientific literature on 99mTc blood cell labeling techniques.
• Discussion of mechanisms involved in various labeling approaches.
• Summary of recent advancements, including the monoclonal antibody approach.

Main Results:

• Red blood cell labeling with 99mTc is well-established.
• Leukocyte and platelet labeling techniques are still developing but improving.
• Monoclonal antibody approach shows potential for in vivo cell labeling.

Conclusions:

• While red blood cell labeling is mature, leukocyte and platelet labeling are advancing.
• Emerging techniques aim for simplicity, convenience, and reproducibility.
• The monoclonal antibody approach offers the most promising future for in vivo cell labeling, overcoming current limitations.